We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biosyntia Recieves Investment for a Bio-based Vitamin Production Platform

News   May 27, 2015

 
Biosyntia  Recieves Investment for a Bio-based Vitamin Production Platform
 
 
 

RELATED ARTICLES

The Source of Stem Cells Points to Two Proteins

News

Negative feedback between HIPPO and Par complex components ensure robust lineage segregation in mice.

READ MORE

From Fibroblast to Antigen-presenting Dendritic Cell: a Pioneering Approach

News

Direct programming of mouse and human skin cells into antigen-presenting dendritic cells opens up the possibility of developing novel dendritic cell-based immunotherapies against cancer.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE